相关实验视频

Updated: Jun 2, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

皮质纤维瘤突起体,版本1.2025,NCCN临床实践指南在瘤学

Jeremy Bordeaux¹, Rachel Blitzblau², Sumaira Z Aasi³

¹Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Journal of the National Comprehensive Cancer Network : JNCCN

|January 17, 2025

概括

皮肤纤维瘤突起 (DFSP) 是一种罕见的皮肤癌. 有负边缘的外科切除是尽量减少复发的关键,尽管对于困难的病例存在其他治疗方法.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
手术病理学手术病理学

背景情况:

皮肤纤维瘤突起 (DFSP) 是一种罕见的皮肤恶性瘤.
外国外交政策的特点是广泛的局部透和高复发率.
转移是不常见的,但纤维沙瘤变体具有更高的风险.

研究的目的:

总结一下皮肤纤维瘤突起体 (DFSP) 的关键方面.
为了强调手术边缘在DFSP治疗中的重要性.
概述不可切除或复发性DFSP的替代治疗方式.

主要方法:

对Dermatofibrosarcoma protuberans的现有文献的审查.
分析治疗策略,包括手术切除,放射治疗和全身治疗.
引用NCCN瘤学临床实践指南.

主要成果:

有负边缘的外科切除是DFSP的主要治疗方法.
实现负边际对于最小化局部复发至关重要.
放射治疗和全身治疗是可行的选择,当完全切除是不可行的.

结论:

皮肤纤维瘤突起症需要仔细的手术管理,以防止复发.
像纤维瘤性DFSP这样的侵略性变体需要迅速和潜在的多式联络治疗.
遵守既定的指导方针,如NCCN指导方针,可以确保最佳的患者护理.

更多相关视频

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...